Bayview Pharmacy's Phenylpropanolamine HCl 10%/Pentoxifylline 5% Topical Lipoderm® (Vet) is a semisolid formulation dispensed through a pump mechanism. This allows for easy and precise application on the skin, providing targeted treatment for conditions such as atopy, pruritus, dermatitis, alopecia, and pyoderma in animals. The gel-like consistency aids in the absorption of active ingredients.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a veterinarian's order for one animal patient. Not FDA-approved.
Phenylpropanolamine is an FDA-approved animal drug. Animal Drugs@FDA lists PROIN Chewable Tablets, PROIN ER and a generic phenylpropanolamine hydrochloride tablet. The PROIN label says it is for oral use in dogs only and is indicated for the control of urinary incontinence due to urethral sphincter hypotonus in dogs. In 2000, FDA asked all drug companies to stop marketing human medicines containing phenylpropanolamine after warning of a risk of bleeding into the brain (hemorrhagic stroke). Compounded preparations are not FDA-approved and are dispensed only on a veterinarian's prescription for an individual animal.
The PROIN label warns it may raise blood pressure and advises caution in dogs with heart, liver or kidney disease, high blood pressure, diabetes or glaucoma. Common study side effects were vomiting, poor appetite, weight loss and behavior changes. Dogs have chewed through closed bottles of flavored tablets; store it securely and call your veterinarian if a pet eats extra. In voluntary post-approval reports, agitation, tremors and heart rhythm changes were reported more often at higher than recommended doses. Deaths, including euthanasia, were also reported, though the label notes a causal link cannot always be established. Safety in breeding, pregnant or nursing dogs has not been studied. Ask your veterinarian or pharmacist about other medicines and supplements your animal takes.
Because approved phenylpropanolamine products exist for dogs, compounding from an approved product is extralabel use under AMDUCA, permitted under 21 CFR 530.13(b) only when no approved animal or human drug, used as labeled or in conformity with the extralabel criteria of part 530, will, in the available dosage form and concentration, appropriately treat the condition diagnosed; 530.13(a) excludes compounding from bulk drugs. Phenylpropanolamine does not appear on FDA's GFI #256 list of bulk drug substances for office stock in nonfood-producing animals (list updated 10/05/2026). The PROIN label lists cautions with sympathomimetics, tricyclic antidepressants, MAO inhibitors and halogenated anesthetics. No FDA CVM safety communication on phenylpropanolamine was found in this review.
No FDA-approved animal drug contains pentoxifylline; Animal Drugs@FDA returns no pentoxifylline products. Pentoxifylline is an FDA-approved human medicine. The TRENTAL extended-release tablet label describes it as a xanthine derivative indicated for intermittent claudication caused by chronic occlusive arterial disease of the limbs in people. The Merck Veterinary Manual says it has been used in limited numbers of animals for conditions including vasculitis, canine familial dermatomyositis, ear margin dermatosis and atopic dermatitis. These are not FDA-approved uses in animals. Compounded preparations are not FDA-approved and are dispensed only on a veterinarian's prescription for an individual animal.
The Merck Veterinary Manual notes stomach and intestinal side effects, such as nausea and vomiting, in animals. The human TRENTAL label says not to use it in patients with recent bleeding in the brain or retina, or in patients who have not tolerated it or related methylxanthines such as caffeine, theophylline and theobromine. The label adds that bleeding has been reported in people with or without blood thinners, antiplatelet drugs or NSAIDs, that it can raise blood levels of theophylline, and that cimetidine and some antibiotics and antidepressants can raise pentoxifylline levels. Tell your veterinarian if your animal has a bleeding problem or takes a blood thinner. Ask your veterinarian or pharmacist about other medicines and supplements your animal takes.
With no approved animal product, pentoxifylline use in animals is extralabel use of an approved human drug, permitted in nonfood-producing animal practice under 21 CFR 530.30 except when public health is threatened; compounding from an approved human product falls under 530.13(b), and 530.13(a) states that part 530 does not permit compounding from bulk drugs. Pentoxifylline is not on FDA's GFI #256 office stock list; FDA lists it as currently under review for dogs, cats and horses (both lists updated 10/05/2026). Merck describes rheologic and immunologic effects, including increased red and white cell deformability and reduced monocyte TNF-alpha production.
Bayview Pharmacy is pleased to present the compounded medication, Phenylpropanolamine HCl 10%/Pentoxifylline 5% Topical Lipoderm® (Vet), designed to treat a range of disease states. This unique formulation combines the therapeutic benefits of two active ingredients, Phenylpropanolamine HCl and Pentoxifylline, to alleviate symptoms associated with various conditions.
Phenylpropanolamine HCl is an alpha-adrenergic agonist that effectively reduces inflammation and swelling. On the other hand, Pentoxifylline is a potent vasodilator that enhances blood flow and mitigates pain. The synergistic action of these two ingredients can provide symptomatic relief from a multitude of conditions, including but not limited to arthritis, muscle spasms, and joint pain.
This compounded medication is a semisolid formulation dispensed through a pump mechanism, facilitating easy and precise application on the skin for targeted treatment. The gel-like consistency allows for optimal absorption of the active ingredients, ensuring maximum therapeutic effect. It is designed for topical application to the affected area, providing targeted relief right where it's needed.
It is crucial to adhere to the instructions provided by your healthcare provider when using this medication. If you have any queries or concerns about using this formulation, please do not hesitate to contact us at Bayview Pharmacy. We are committed to providing comprehensive care and support to all our patients.
Phenylpropanolamine HCl 10%/Pentoxifylline 5% Topical Lipoderm® (Vet) is a compounded formulation designed for targeted treatment of various disease states. This includes skin conditions, allergies, and inflammation. The formulation is dispensed through a pump mechanism, which allows for easy and precise application on the skin.
The formulation contains two active ingredients: Phenylpropanolamine HCl and Pentoxifylline. Phenylpropanolamine HCl is a sympathomimetic amine that acts as an alpha-adrenergic agonist. This can help reduce inflammation and itching. On the other hand, Pentoxifylline is a xanthine derivative that acts as a vasodilator. This can improve blood flow and reduce inflammation. Together, these two active ingredients can provide relief from the symptoms associated with these disease states.
Patients should be aware that this formulation may cause skin irritation, redness, or a burning sensation at the application site. If these side effects occur, patients should discontinue use and contact their healthcare provider. Additionally, this formulation should not be used on broken or irritated skin.
Prescribers should be aware that this formulation should not be used in patients with known hypersensitivity to any of the active ingredients. Furthermore, this formulation should not be used in patients with severe cardiovascular disease, hypertension, or glaucoma.
If you have any questions about the use of Phenylpropanolamine HCl 10%/Pentoxifylline 5% Topical Lipoderm® (Vet) for the treatment of these disease states, please reach out to your healthcare provider.
Phenylpropanolamine HCl 10%/Pentoxifylline 5% Topical Lipoderm® (Vet) is a compounded veterinary medication designed to address various skin conditions in animals. This unique formulation combines the anti-inflammatory properties of phenylpropanolamine hydrochloride and pentoxifylline, providing targeted relief from symptoms such as inflammation and itching.
The phenylpropanolamine hydrochloride component functions by inhibiting the release of histamine, a substance that triggers inflammation and itching. On the other hand, pentoxifylline enhances blood flow to the affected area, further reducing inflammation and itching. This dual-action approach ensures comprehensive treatment of the affected area.
This medication is dispensed as a semisolid formulation through a pump mechanism, which allows for easy and precise application. The gel-like consistency ensures that the active ingredients are absorbed effectively through the skin and into the bloodstream for targeted treatment.
Phenylpropanolamine HCl 10%/Pentoxifylline 5% Topical Lipoderm® (Vet) is indicated for a range of skin conditions in animals, including but not limited to allergic dermatitis, flea allergy dermatitis, and atopic dermatitis.
As with any medication, it is crucial to follow the directions on the label and use the medication as directed. Avoid contact with the eyes and other sensitive areas when applying this medication.
If you have any questions or concerns about Phenylpropanolamine HCl 10%/Pentoxifylline 5% Topical Lipoderm® (Vet), or if you need further information on how it works, please do not hesitate to reach out. We are committed to providing the necessary support for you and your pet's health.
This is a compounded formulation that combines Phenylpropanolamine HCl and Pentoxifylline in a semisolid form. It is dispensed through a pump mechanism for easy and precise application on the skin.
The formulation has a gel-like consistency, which makes it easy to apply on the skin.
This formulation is applied topically on the skin. It is dispensed through a pump mechanism, which allows for easy and precise application.
The pump mechanism facilitates easy and precise application of the formulation on the skin. It ensures that the right amount of the formulation is applied each time.
The active ingredients in this formulation are Phenylpropanolamine HCl and Pentoxifylline.
Phenylpropanolamine HCl is a decongestant that shrinks blood vessels in the nasal passages. It is used to treat symptoms of nasal and sinus congestion.
Pentoxifylline is a medication that improves blood flow. It is used to treat intermittent claudication (pain in the legs that worsens with walking and improves with rest) caused by peripheral artery disease.
This formulation is specifically designed for veterinary use. However, it is always recommended to consult with a veterinarian before using any new medication on your pet.
While the active ingredients in this formulation are primarily used to treat nasal and sinus congestion and intermittent claudication, they may have other uses as well. Always consult with a veterinarian for the appropriate use of this medication.
If your pet has an adverse reaction to this formulation, stop using it immediately and consult with a veterinarian. Signs of an adverse reaction may include skin irritation, changes in behavior, or changes in eating or drinking habits.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)